Senior Director, Benefit/Risk Medical Adviser to the QPPV at Regeneron Pharmaceuticals | GB | Rezi

Senior Director, Benefit/Risk Medical Adviser to the QPPV at Regeneron Pharmaceuticals

Senior Director, Benefit/Risk Medical Adviser to the QPPV

Regeneron Pharmaceuticals · GB

Today

Senior Director, Benefit/Risk Medical Adviser to the QPPV

Regeneron Pharmaceuticals · GB

a day ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

Regeneron is seeking a Senior Director, Benefit/Risk Medical Adviser EU/UK to provide authoritative medical, safety and benefit-risk advice supporting oversight of authorised products throughout their lifecycle. You will combine clinical judgement with qualitative and quantitative approaches, including patient preferences, real-world data and epidemiological evidence, while partnering with colleagues across Global Patient Safety, Regulatory Affairs, Clinical Development and other functions.

Responsibilities

  • Advise the QPPV on signal validation, evaluation and prioritisation, benefit-risk assessments, Risk Management Plans and health hazard assessments.
  • Shape medical and safety strategy across clinical development and the post-authorisation lifecycle, including emerging clinical trial data and evolving safety evidence.
  • Provide expert input to regulatory submissions, aggregate safety reports, safety communications and responses to health authority questions, requests and referrals.
  • Apply qualitative and quantitative benefit-risk approaches using clinical, epidemiological, real-world and patient-preference evidence, where appropriate.
  • Advise on PASS protocols and the appropriate use and interpretation of epidemiology, pharmacoepidemiology and real-world data.
  • Develop and optimise CCSI, RMP, aggregate reporting and pharmacovigilance processes, identifying gaps and strengthening QPPV oversight.
  • Partner across safety, regulatory, clinical, quality, legal, commercial, local pharmacovigilance and product supply functions while contributing to governance and inspection readiness.
  • Provide credible medical challenge, translate complex safety science into clear advice and influence senior stakeholders without direct authority.

Requirements

  • A medical qualification, such as MBChB, MBBS or MD, with a current or historic medical licence.
  • Extensive post-qualification experience in drug safety or pharmacovigilance within the pharmaceutical or biotechnology industry, or a health authority.
  • Deep knowledge of EU GVP and the EU/UK pharmacovigilance legislative framework, with working knowledge of US FDA safety reporting requirements.
  • Proven expertise in signal evaluation, qualitative and quantitative benefit-risk assessment, risk management planning and the safety aspects of regulatory submissions.
  • Strong knowledge of relevant ICH guidelines and the application of real-world, epidemiological and pharmacoepidemiological evidence.
  • Authoritative medical judgement, clear scientific communication and the ability to operate credibly with senior and cross-functional stakeholders.
  • Experience supporting or deputising for a QPPV, working within a QPPV Office, or supporting inspections and audits is preferred.
  • A Pharmaceutical Medicine qualification, specialist registration or experience across additional regulatory jurisdictions is preferred.
  • Experience applying patient-preference evidence or quantitative benefit-risk methods, or an additional EU language relevant to the location, is preferred.

Skills

  • Signal validation
  • Signal evaluation
  • Signal prioritisation
  • Benefit-risk assessments
  • Risk Management Plans
  • Health hazard assessments
  • Medical strategy
  • Safety strategy
  • Clinical development
  • Post-authorisation lifecycle
  • Regulatory submissions
  • Aggregate safety reports
  • Safety communications
  • Health authority questions
  • Qualitative benefit-risk approaches
  • Quantitative benefit-risk approaches
  • Clinical evidence
  • Epidemiological evidence
  • Real-world data
  • Patient-preference evidence
  • PASS protocols
  • Epidemiology
  • Pharmacoepidemiology
  • CCSI development
  • RMP development
  • Aggregate reporting
  • Pharmacovigilance processes
  • Cross-functional collaboration
  • Scientific communication
  • Stakeholder influence

Location

  • Uxbridge (Hybrid)

Work Type

  • Hybrid

Experience Level

  • Senior Director
  • Extensive post-qualification experience

Education Level

  • Medical qualification (MBChB, MBBS or MD)
  • Current or historic medical licence
  • Pharmaceutical Medicine qualification (preferred)

Benefits

  • Annual bonuses or other incentive plans
  • Equity awards
  • Pension or retirement benefits
  • 401(k) company match
  • Health and wellness programs
  • Fitness centers
  • Insurance benefits (medical, dental, vision, life and disability)
  • Paid time off
  • Family support benefits

About the Company

  • At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases.

Equal Opportunity

  • Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law.
  • Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.